Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (for New Mexico Only)
Summary
UnitedHealthcare Community Plan of New Mexico revised its coverage policy for TARE/SIRT (yttrium-90 microspheres) for liver cancer treatment, effective December 1, 2026. The key change replaced "metastasis from uveal/ocular melanoma" with "metastasis from uveal melanoma" in the list of covered indications. The policy also updated definitions and clinical evidence sections. Coverage applies to patients 19+ years with ECOG Performance Status 0-2; patients under 19 are automatically covered without prior review.
Get alerts when payers change rules like this one
We check UnitedHealthcare and other payers every day and email you when a change matches your specialty and state.